Delivery Order SPE2D021DA002-SPE2D324F069E

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $14K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,381.17, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the supply of ISENTRESS 400 MG TABLET, with a period of performance through June 21, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,603.22 firm fixed-price delivery order is for the supply of Isentress 100 mg chewable tablets with an ultimate completion date of December 20, 2022. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award, valued at $1,381.17, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4566483326 - ISENTRESS 400 MG TABLET, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of Isentress 400 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical provides a wide...
This federal contract award, valued at $17,955.21, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's Medical Supply Chain program and does not have a set-aside designation. The award is for the delivery of ISENTRESS 400 MG TABLET, a prescription pharmaceutical product, with an ultimate completion date of May 3, 2024. This contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) under the DLA Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $24,861.06, is for the delivery of the pharmaceutical product Isentress 400 mg tablets. The contract has a firm fixed-price pricing type and a completion date of July 5, 2024. DMS Pharmaceutical Group Inc. holds a larger...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Isentress 400 mg tablets. The contract, valued at $1,381.17, has an ultimate completion date of April 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive...
The federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,381.17 firm fixed-price delivery order is for ISENTRESS 400 MG TABLET and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,905.85 firm fixed-price contract is for the supply of Isentress 400 mg tablets, with a period of performance through March 29, 2024. The award is issued under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract SPE2DB, which enables the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $11,049.36 contract provides for the delivery of Isentress 400 mg tablets to support the medical supply needs of U.S. government agencies. This order is issued against DMS Pharmaceutical Group's indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which has a ceiling value of up...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D324F069E
    Delivery Order

This federal contract award, valued at $13,811.70, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Isentress 400 mg tablets, with a completion date of June 25, 2024.

DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This award appears to be one such delivery order under that larger IDC vehicle. The contract has no set-aside designation.

Generated 9/23/24, 9:58 AM